SARS-CoV-2 and ACE2 nexus

Corona virus

Keywords: 2019-nCoV, ACE-2, COVID-19, SARS-CoV-2

Downloads

Download data is not yet available.

Author Biography

Mehnaaz Sameera Arifuddin, Deccan College of Medical Sciences

Department of Physiology, Associate Professor

References


  1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15; 395(10223):497-506. [Pubmed] [Crossref]

  2. Tikellis C, Thomas MC. Angiotensin-Converting Enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept. 2012; 2012:256294. [Pubmed] [Crossref]

  3. ACE2 angiotensin I converting enzyme 2 [Homo sapiens (human)] [Internet]. Bethesda (MD): National Center for Biotechnology Information, U.S. National Library of Medicine; 2020. Available from: https://www.ncbi.nlm.nih.gov/gene/59272

  4. Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020 Mar 27; 367(6485):1444-1448. [Pubmed] [Crossref]

  5. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005 Aug; 11(8):875-9. [Pubmed] [Crossref]

  6. Simões e Silva AC, Silveira KD, Ferreira AJ, Teixeira MM. ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol. 2013 Jun; 169(3):477-92. [Pubmed] [Crossref]

  7. Ciaglia E, Vecchione C, Puca AA. COVID-19 infection and circulating ACE2 levels: Protective role in women and children. Front Pediatr. 2020 Apr 23; 8:206. [Pubmed] [Crossref]

  8. Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020 Apr 1; 130(4):1545-1548. [Pubmed] [Crossref]

  9. Bozkurt B, Kovacs R, Harrington B. Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. J Card Fail. 2020 May; 26(5):370. [Pubmed] [Crossref]

  10. Callaway E. Coronavirus vaccine trials have delivered their first results - but their promise is still unclear. Nature. 2020 May; 581(7809):363-364. [Pubmed] [Crossref]


QR code
Published
2020-06-30
How to Cite
1.
Arifuddin M. SARS-CoV-2 and ACE2 nexus. Annals of Medical Physiology [Internet]. 30Jun.2020 [cited 14Jul.2020];4(1):1-. Available from: http://amphysiol.com/index.php/amp/article/view/v4i1.120578
Section
Editorial

Plum X metrics

Article level metrics are shown here